Investigates calcium channels and PI3K/AKT/eNOS signaling in rats, suggesting possible therapeutic targets.
Cardiac hypertrophy alters vascular function and promotes myocardial damage via oxidative stress and inflammation, with calcium channels and the PI3K/AKT/eNOS signalling pathway being pivotal in vascular reactivity. Nonetheless, their precise role in acetylcholine (ACh)-mediated vascular responses during hypertrophy remains little elucidated. The study aims to investigate calcium channel functions and endothelial PI3K/AKT/eNOS signalling in modulating vascular reactivity in a rat model of cardiac hypertrophy. Aortic rings from control and ISO-treated rats were mounted in organ baths. Cumulative ACh dose–response curves (DRC) were obtained at baseline and after preincubation with Nω-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase (NOS) blocker, PI3K inhibitor, AKT inhibitor, Mas receptor antagonist (Mas blocker), and amlodipine (L-type Ca²⁺ blocker). Potency (pD₂), maximal relaxation (Emax), and area under the curve (AUC) were compared. In control vessels, Mas receptor blockade, AKT inhibition, and L-NAME each reduced ACh-induced relaxation—confirming that PI3K/AKT/eNOS-dependent nitric oxide (NO) signalling drives vasodilation. Amlodipine slightly lowered relaxation parameters, suggesting that Ca²⁺ entry supports maximal NO production. After ISO treatment, these effects were reversed: Mas blockade and amlodipine enhanced relaxation, while AKT inhibition increased pD₂ and AUC without reducing Emax. L-NAME caused weaker inhibition, reflecting impaired NO signalling. PI3K inhibition had no effect in either condition, and overall AUC changes were minimal. Isoproterenol disrupts the balance between Ca²-dependent and phosphorylation-dependent activation of eNOS, reducing NO bioavailability and rewiring Mas/AKT signalling. Reducing pathological Ca²⁺ influx and dampening AKT activity reverse endothelial responsiveness; however, Mas signalling shifts from endothelial vasoprotective in physiology to maladaptive in hypertrophy. Consequently, the L-type Ca²⁺ channels, AKT, and the Mas axis appear to be reasonable targets for rebalancing endothelial sensitivity in hypertrophic conditions.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: